BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Colorcon
Merck
Express Scripts
Federal Trade Commission
Dow
Healthtrust
Cerilliant
Moodys
Novartis

Generated: January 17, 2018

DrugPatentWatch Database Preview

ARCAPTA NEOHALER Drug Profile

« Back to Dashboard

When do Arcapta Neohaler patents expire, and when can generic versions of Arcapta Neohaler launch?

Arcapta Neohaler is a drug marketed by Sunovion Pharms Inc and is included in one NDA. There are five patents protecting this drug.

This drug has eighty-four patent family members in thirty-eight countries.

The generic ingredient in ARCAPTA NEOHALER is indacaterol maleate. Two suppliers are listed for this compound. Additional details are available on the indacaterol maleate profile page.
Summary for ARCAPTA NEOHALER
International Patents:84
US Patents:5
Applicants:1
NDAs:1
Suppliers / Packagers: 2
Bulk Api Vendors: 21
Patent Applications: 686
Drug Prices:see details
DailyMed Link:ARCAPTA NEOHALER at DailyMed
Drug patent expirations by year for ARCAPTA NEOHALER
Pharmacology for ARCAPTA NEOHALER

US Patents and Regulatory Information for ARCAPTA NEOHALER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sunovion Pharms Inc ARCAPTA NEOHALER indacaterol maleate POWDER;INHALATION 022383-001 Jul 1, 2011 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Sunovion Pharms Inc ARCAPTA NEOHALER indacaterol maleate POWDER;INHALATION 022383-001 Jul 1, 2011 RX Yes Yes ➤ Subscribe ➤ Subscribe Y Y ➤ Subscribe
Sunovion Pharms Inc ARCAPTA NEOHALER indacaterol maleate POWDER;INHALATION 022383-001 Jul 1, 2011 RX Yes Yes ➤ Subscribe ➤ Subscribe Y Y ➤ Subscribe
Sunovion Pharms Inc ARCAPTA NEOHALER indacaterol maleate POWDER;INHALATION 022383-001 Jul 1, 2011 RX Yes Yes ➤ Subscribe ➤ Subscribe Y Y ➤ Subscribe
Sunovion Pharms Inc ARCAPTA NEOHALER indacaterol maleate POWDER;INHALATION 022383-001 Jul 1, 2011 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sunovion Pharms Inc ARCAPTA NEOHALER indacaterol maleate POWDER;INHALATION 022383-001 Jul 1, 2011 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for ARCAPTA NEOHALER

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,040,559 BETA2-adrenoceptor agonists ➤ Subscribe
7,622,483 .beta.2-adrenoceptor agonists ➤ Subscribe
7,820,694 Beta-2-adrenoreceptor agonists ➤ Subscribe
8,436,017 Beta-2-adrenoreceptor agonists ➤ Subscribe
8,283,362 Beta-2-adrenoreceptor agonists ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for ARCAPTA NEOHALER

Supplementary Protection Certificates for ARCAPTA NEOHALER

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
00437 Netherlands ➤ Subscribe PRODUCT NAME: INDACATEROL, DESGEWENST IN DE; REGISTRATION NO/DATE: EU/1/09/593/001-010 20091130
7/2010 Austria ➤ Subscribe PRODUCT NAME: INDACATEROL UND PHARMAZEUTISCH ANNEHMBARE SALZE DAVON
1183240/01 Switzerland ➤ Subscribe FORMER REPRESENTATIVE: VOSSIUS AND PARTNER, CH
393 Luxembourg ➤ Subscribe PRODUCT NAME: GLYCOPYRRONIUM OU UN SEL DE CELUI-CI, PLUS PARTICULIEREMENT LE SEL BROMURE, COMBINE A INDACATEROL OU UN SEL DE CELUI-CI, PLUS PARTICULIEREMENT LE SEL MALEATE. FIRST REGISTRATION: 20130923
2014 00020 Denmark ➤ Subscribe PRODUCT NAME: GLYCOPYRRONIUM ELLER ET SALT DERAF, ISAER BROMIDSALTET, I KOMBINATION MED INDACATEROL ELLER ET SALT DERAF, ISAER MALEATSALTET; REG. NO/DATE: EU/1/13/862 20130919
C009/2010 Ireland ➤ Subscribe SPC009/2010: 20100813, EXPIRES: 20241129
2010 00006 Denmark ➤ Subscribe PRODUCT NAME: INDACATEROL ELLER ET SALT DERAF, HERUNDER INDACATEROLMALEAT
3 Finland ➤ Subscribe
C0006 France ➤ Subscribe PRODUCT NAME: INDACATEROL OU UN SEL DE CELUI-CI; REGISTRATION NO/DATE IN FRANCE: EU/1/09/593/001 DU 20091130; REGISTRATION NO/DATE AT EEC: EU/1/09/593/001-010 DU 20091130
C/GB10/009 United Kingdom ➤ Subscribe PRODUCT NAME: INDACATEROL OR A SALT THEREOF; REGISTERED: UK EU/1/09/593/001 20091130; UK EU/1/09/593/002 20091130; UK EU/1/09/593/003 20091130; UK EU/1/09/593/004 20091130; UK EU/1/09/593/005 20091130; UK EU/1/09/593/006 20091130; UK EU/1/09/593/007 20091130; UK EU/1/09/593/008 20091130; UK EU/1/09/593/009 20091130; UK EU/1/09/593/010 20091130
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Fuji
Mallinckrodt
Covington
US Department of Justice
Citi
Medtronic
Federal Trade Commission
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot